miR-575 IS ASSOCIATED WITH WORSE SURVIVAL OF GBM PATIENTS AND ACTS AS A NOVEL ONCOGENE THROUGH TARGETING p27/CDKN1B AND BLID/BRCC2

Tiantian Cui, Ashley Gray, Erica Hlavin Bell, Joseph McElroy, Marjolein Geurts, Wei Meng, Jahar Haque, Pierre Robe, Arnab Chakravarti

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)48-48
JournalNeuro-Oncology
Volume20
Publication statusPublished - Nov 2018

Cite this